Retraction Retraction dated 2023-11-08
Click to view Retraction: https://doi.org/10.1038/s41586-023-06731-z
-
Authors
Yarmarkovich, Mark
Marshall, Quinlen F. https://orcid.org/0000-0002-4736-9716
Warrington, John M.
Premaratne, Rasika
Farrel, Alvin
Groff, David
Li, Wei
di Marco, Moreno
Runbeck, Erin
Truong, Hau
Toor, Jugmohit S.
Tripathi, Sarvind https://orcid.org/0000-0002-6959-0577
Nguyen, Son https://orcid.org/0000-0002-0475-5158
Shen, Helena https://orcid.org/0000-0002-0500-441X
Noel, Tiffany
Church, Nicole L.
Weiner, Amber
Kendsersky, Nathan https://orcid.org/0000-0003-0132-8748
Martinez, Dan
Weisberg, Rebecca
Christie, Molly
Eisenlohr, Laurence
Bosse, Kristopher R.
Dimitrov, Dimiter S. https://orcid.org/0000-0002-2258-1024
Stevanovic, Stefan
Sgourakis, Nikolaos G.
Kiefel, Ben R.
Maris, John M. https://orcid.org/0000-0002-8088-7929
- License Information
-
More Information
Article History
Received: 20 April 2021
Accepted: 23 September 2021
First Online: 3 November 2021
Change Date: 8 November 2023
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1038/s41586-023-06731-z
Competing interests
: J.M.M. and M.Y. have equity stake in Tantigen Bio Inc. and HuLA Therapeutics. Both companies have interest in commercializing technologies described herein. B.R.K. is an employee of and has equity interests in Myrio Therapeutics. R.P. and N.L.C. are employees of Myrio Therapeutics. J.M.M., M.Y. and B.R.K. are co-inventors on a patent filed regarding the PHOX2B PC-CAR.
